120
Participants
Start Date
November 30, 2023
Primary Completion Date
March 31, 2032
Study Completion Date
March 31, 2032
Data collection
The schedule of office visits and all treatment regimens will be determined by the treating health care provider. No interventions are administered as part of this protocol (observational study).
RECRUITING
ProPharma, Recruiting Nationwide, Overland Park
VBI Vaccines Inc.
INDUSTRY